Risk of Subsequent Ovarian Cancer After Ovarian Conservation in Young Women With Stage I Endometrioid Endometrial Cancer

被引:38
作者
Matsuo, Koji
Machida, Hiroko
Stone, Rebecca L.
Soliman, Pamela T.
Thaker, Premal H.
Roman, Lynda D.
Wright, Jason D.
机构
[1] Univ Southern Calif, Div Gynecol Oncol, Los Angeles, CA USA
[2] Univ Southern Calif, Dept Obstet & Gynecol, Los Angeles, CA USA
[3] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA
[4] John Hopkins Med, Dept Gynecol & Obstet, Div Gynecol Oncol, Baltimore, MD USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA
[6] Washington Univ, Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, St Louis, MO 63110 USA
[7] Columbia Univ, Coll Phys & Surg, Dept Obstet & Gynecol, Div Gynecol Oncol, New York, NY USA
关键词
PREMENOPAUSAL WOMEN; SURVIVAL; MANAGEMENT; MORTALITY; DISEASE; TIME;
D O I
10.1097/AOG.0000000000002142
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To examine the cumulative incidence of subsequent ovarian cancer among young women with stage I endometrioid endometrial cancer who had ovarian conservation at surgical treatment. METHODS: This retrospective study examined the Surveillance, Epidemiology, and End Results Program to identify women aged younger than 50 years who underwent hysterectomy with ovarian conservation for stage I endometrioid endometrial cancer between 1983 and 2013. Time-dependent risk of ovarian cancer diagnosed during the follow-up after endometrial cancer diagnosis was examined. t RESULTS: Among 1,322 women inhe study cohort, 16 women developed subsequent ovarian cancer with 5- and 10-year cumulative incidences of 1.0% and 1.3%, respectively. Median time to develop subsequent ovarian cancer was 2.4 years, and the majority of subsequent ovarian cancer was diagnosed within the first 3 years from the diagnosis of endometrial cancer (68.8%). The majority of subsequent ovarian cancer was endometrioid type (81.3%) and stage I disease (75.0%). With a median follow-up time of 11.6 years, there were no ovarian cancer deaths. Younger age at endometrial cancer diagnosis was significantly associated with increased risk of subsequent ovarian cancer (10-year cumulative incidences: age younger than 40 compared with 40-49 years, 2.6% compared with 0.4%, hazard ratio 5.00, 95% confidence interval [CI] 1.60-15.7, P=.002). CONCLUSION: Young women with stage I endometrioid endometrial cancer have an approximately 1% risk of developing subsequent ovarian cancer after ovarian conservation at the time of hysterectomy that was associated with favorable tumor factors resulting in good ovarian cancer-specific survival. Our results endorse the importance of genetic testing and close follow-up when counseling about this procedure, especially for those who are younger than 40 years.
引用
收藏
页码:403 / 410
页数:8
相关论文
共 26 条
  • [1] [Anonymous], 2014, Obstet Gynecol, V124, P1042, DOI 10.1097/01.AOG.0000456325.50739.72
  • [2] Effect of Screening on Ovarian Cancer Mortality The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial
    Buys, Saundra S.
    Partridge, Edward
    Black, Amanda
    Johnson, Christine C.
    Lamerato, Lois
    Isaacs, Claudine
    Reding, Douglas J.
    Greenlee, Robert T.
    Yokochi, Lance A.
    Kessel, Bruce
    Crawford, E. David
    Church, Timothy R.
    Andriole, Gerald L.
    Weissfeld, Joel L.
    Fouad, Mona N.
    Chia, David
    O'Brien, Barbara
    Ragard, Lawrence R.
    Clapp, Jonathan D.
    Rathmell, Joshua M.
    Riley, Thomas L.
    Hartge, Patricia
    Pinsky, Paul F.
    Zhu, Claire S.
    Izmirlian, Grant
    Kramer, Barnett S.
    Miller, Anthony B.
    Xu, Jian-Lun
    Prorok, Philip C.
    Gohagan, John K.
    Berg, Christine D.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (22): : 2295 - 2303
  • [3] COX DR, 1972, J R STAT SOC B, V34, P187
  • [4] Edge SB., 2010, AJCC CANC STAGING MA
  • [5] Impact of Wait Times on Survival for Women With Uterine Cancer
    Elit, Lorraine M.
    O'Leary, Erin M.
    Pond, Gregory R.
    Seow, Hsien-Yeang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (01) : 27 - 33
  • [6] Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
    Jacobs, Ian J.
    Menon, Usha
    Ryan, Andy
    Gentry-Maharaj, Aleksandra
    Burnell, Matthew
    Kalsi, Jatinderpal K.
    Amso, Nazar N.
    Apostolidou, Sophia
    Benjamin, Elizabeth
    Cruickshank, Derek
    Crump, Danielle N.
    Davies, Susan K.
    Dawnay, Anne
    Dobbs, Stephen
    Fletcher, Gwendolen
    Ford, Jeremy
    Godfrey, Keith
    Gunu, Richard
    Habib, Mariam
    Hallett, Rachel
    Herod, Jonathan
    Jenkins, Howard
    Karpinskyj, Chloe
    Leeson, Simon
    Lewis, Sara J.
    Liston, William R.
    Lopes, Alberto
    Mould, Tim
    Murdoch, John
    Oram, David
    Rabideau, Dustin J.
    Reynolds, Karina
    Scott, Ian
    Seif, Mourad W.
    Sharma, Aarti
    Singh, Naveena
    Taylor, Julie
    Warburton, Fiona
    Widschwendter, Martin
    Williamson, Karin
    Woolas, Robert
    Fallowfield, Lesley
    McGuire, Alistair J.
    Campbell, Stuart
    Parmar, Mahesh
    Skates, Steven J.
    [J]. LANCET, 2016, 387 (10022) : 945 - 956
  • [7] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS
    KAPLAN, EL
    MEIER, P
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) : 457 - 481
  • [8] Management of Menopausal Symptoms
    Kaunitz, Andrew M.
    Manson, JoAnn E.
    [J]. OBSTETRICS AND GYNECOLOGY, 2015, 126 (04) : 859 - 876
  • [9] Ovarian preservation during the surgical treatment of early stage endometrial cancer: A nation-wide study conducted by the Korean Gynecologic Oncology Group
    Lee, Taek Sang
    Kim, Jae Weon
    Kim, Tae Jin
    Cho, Chi Heum
    Ryu, Sang Young
    Ryu, Hee-Sug
    Kim, Byoung Gie
    Lee, Keun Ho
    Kim, Yong Man
    Kang, Soon-Beom
    [J]. GYNECOLOGIC ONCOLOGY, 2009, 115 (01) : 26 - 31
  • [10] Endometrial and ovarian cancer in women with Lynch syndrome: update in screening and prevention
    Lu, Karen H.
    Daniels, Molly
    [J]. FAMILIAL CANCER, 2013, 12 (02) : 273 - 277